Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2024 · 57 positions · Total reported value $2.28B · Top-10 concentration 55.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Cormorant Asset Management, LP disclosed 57 equity positions with a combined reported value of $2.28B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were MLTX ($426.66M), EYPT ($142.48M), ACLX ($123.80M). By sector, the heaviest allocations are Health Care 66.2%, Industrials 6.3%. Versus the prior quarter, allocation shifted toward Health Care (+4.9pp) and away from Other (-4.5pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 57% of names.

The largest new positions opened in Q1 2024 were CRBP ($79.46M), NAMS ($35.48M), CGON ($35.12M).

Of the 2 positions fully exited versus the prior quarter, the largest were AMAM ($159.93M), RYZB ($75.44M), IMVT ($49.08M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • CRBP CORBUS PHARMACEUTICALS HLDGS · $79.46M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $35.48M
  • CGON CG ONCOLOGY INC · $35.12M
  • MRUS MERUS N V · $32.20M
  • HLXB HELIX ACQUISITION CORP II · $30.25M
  • TRML TOURMALINE BIO INC · $28.62M
  • JANX JANUX THERAPEUTICS INC · $28.24M
  • ARQT ARCUTIS BIOTHERAPEUTICS INC · $21.06M

Fully Exited (vs previous quarter)

  • AMAM AMBRX BIOPHARMA INC · prev qtr: $159.93M
  • RYZB RAYZEBIO INC · prev qtr: $75.44M
  • IMVT IMMUNOVANT INC · prev qtr: $49.08M
  • CBAY CYMABAY THERAPEUTICS INC · prev qtr: $42.52M
  • OLMA OLEMA PHARMACEUTICALS INC · prev qtr: $34.47M · history
  • SNDX SYNDAX PHARMACEUTICALS INC · prev qtr: $25.39M
  • HARP HARPOON THERAPEUTICS INC · prev qtr: $22.55M
  • AXNX AXONICS INC · prev qtr: $15.56M

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 66.2%
Materials 0.2%
Other 27.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.49M $426.66M 18.72%
18.72%
Hold
2 6.89M $142.48M 6.25%
6.25%
Add
3 1.78M $123.80M 5.43%
5.43%
Add
4 2.70M $107.03M 4.70%
4.70%
Add
5 3.20M $99.04M 4.34%
4.34%
Reduce
6 1.31M $79.94M 3.51%
3.51%
Add
7 2.02M $79.46M 3.49%
Form 4 · 1 →
3.49%
New
8 2.14M $77.76M 3.41%
3.41%
Reduce
9 3.35M $72.43M 3.18%
3.18%
Add
10 3.01M $54.84M 2.41%
2.41%
Add
11 1.15M $53.83M 2.36%
2.36%
Hold
12 3.57M $53.38M 2.34%
2.34%
Hold
13 529.17K $47.63M 2.09%
2.09%
Hold
14 685.00K $46.79M 2.05%
2.05%
Add
15 6.62M $42.21M 1.85%
1.85%
Add
16 1.71M $39.55M 1.74%
1.74%
Hold
17 1.50M $35.48M 1.56%
1.56%
New
18 800.00K $35.12M 1.54%
1.54%
New
19 3.14M $35.03M 1.54%
1.54%
Hold
20 616.96K $33.74M 1.48%
1.48%
Add
21 715.00K $32.20M 1.41%
1.41%
New
22 1.07M $31.63M 1.39%
1.39%
Reduce
23 2.13M $30.46M 1.34%
1.34%
Hold
24 2.91M $30.25M 1.33%
1.33%
New
25 3.25M $29.38M 1.29%
1.29%
Hold
26 1.25M $28.62M 1.26%
1.26%
New
27 750.00K $28.24M 1.24%
1.24%
New
28 538.71K $27.42M 1.20%
1.20%
Reduce
29 1.18M $26.39M 1.16%
1.16%
Hold
30 550.00K $23.83M 1.04%
1.04%
Hold
31 400.00K $23.51M 1.03%
1.03%
Reduce
32 2.12M $21.06M 0.92%
0.92%
New
33 450.00K $19.75M 0.87%
0.87%
Hold
34 1.10M $18.77M 0.82%
0.82%
New
35 1.30M $18.30M 0.80%
0.80%
New
36 1.00M $16.95M 0.74%
0.74%
New
37 575.00K $15.60M 0.68%
0.68%
Hold
38 2.71M $14.90M 0.65%
0.65%
New
39 1.35M $14.59M 0.64%
0.64%
New
40 625.00K $13.50M 0.59%
0.59%
New
41 2.60M $11.65M 0.51%
0.51%
New
42 5.56M $11.01M 0.48%
0.48%
New
43 440.00K $10.93M 0.48%
0.48%
New
44 300.00K $9.91M 0.43%
0.43%
New
45 3.30M $9.52M 0.42%
0.42%
Reduce
46 250.00K $9.48M 0.42%
0.42%
Reduce
47 515.00K $9.20M 0.40%
0.40%
New
48 300.00K $8.08M 0.35%
0.35%
Reduce
49 125.00K $7.78M 0.34%
0.34%
Hold
50 561.60K $6.35M 0.28%
0.28%
Hold

FAQ

What did Cormorant Asset Management, LP buy in 2024-Q1?

In its 2024-Q1 13F filing, Cormorant Asset Management, LP reported 57 equity positions worth $2.28B in aggregate; its largest disclosed positions were MLTX ($426.66M), EYPT ($142.48M), ACLX ($123.80M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $2.28B of long equity holdings across 57 positions as of 2024-Q1. Top-10 holdings account for 55.4% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →